We selected disease endpoints showing association to the GDF15 plasma levels, namely type 2 diabetes, atherosclerosis (excluding cerebral, coronary, and PAD), COPD, psychiatric disorders, and malignant neoplasm of respiratory system and intrathoracic organs (Supplementary file 2d). Here, GDF15 is linked to psychiatric disorder.